Director Harold Schnitzer Diabetes Health Center Oregon Health and Science University
Endocrinology
Dr. Andrew J. Ahmann, MD
|
|
Give Review
Andrew Ahmann works in the field of Endocrinology. He went to medical school at University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is one of the top medical schools in the US. University of Colorado Denver School of Medicine is ranked 35 in research and 8 in primary care medicine He received 2 awards: "America's Top Doctors" and "CMS Meaningful Use Stage 1 Certification". Andrew Ahmann is a published MD. He published 34 publications, including: 'The role of T lymphocytes in autoimmune thyroid disease.' He accepts Medicare.
Publications
- Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 Diabetes: a randomized, placebo-...
- Response to Comment on Wong et al. Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry. Diabetes Care 2014;37:2702-2709.
- Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry.
- Accuracy and acceptability of the 6-day enlite continuous subcutaneous glucose sensor.
- Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen Versus Vial-and-Syringe Insulin Delivery in Patients with Type 2 Diabetes.
- Threshold-based insulin-pump interruption for reduction of Hypoglycemia.
- Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP).
- Treating to target: implementing an effective Diabetes care paradigm for managed care.
- Designing and implementing insulin infusion protocols and order sets.
- Safety profile and metabolic effects of 14 days of treatment With DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-g...
- The impact of Diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
- Advancing insulin therapy in type 2 Diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus b...
- Ultradian variation of blood glucose in intensive care unit patients receiving insulin infusions.
- Guidelines and performance measures for Diabetes.
- Inpatient management of hospitalized patients with type 2 Diabetes.
- What to do when two oral agents fail to control type 2 Diabetes--a matter of opinion or a matter of fact?
- Current oral agents for type 2 Diabetes. Many options, but which to choose when?
- ASPIRE In-Home: Rationale, Design, and Methods of a Study to Evaluate the Safety and Efficacy of Automatic Insulin Suspension for Nocturnal Hypoglycemia.
- Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile.
- Antibodies to porcine eye muscle in patients With Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblottin...
- Lessons on developing a better basal insulin.
- Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase.
- Application of comparative effectiveness research in evaluation of treatments for type 2 Diabetes mellitus.
- Patient-specific insulin-resistance-guided infusion improves glycemic control in cardiac surgery.
- Effectiveness of sensor-augmented insulin-pump therapy in type 1 Diabetes.
- Management of Diabetes and hyperglycemia in hospitals.
- Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 Diabetes.
- Reduction of hospital costs and length of stay by good control of blood glucose levels.
- The role of T lymphocytes in autoimmune Thyroid disease.
- Immunoglobulin and T cell antigen receptor gene arrangements indicate that the immune response in autoimmune Thyroid disease is polyclonal.
- [Molecular genetic detection of polyclonal immune response in autoimmune Thyroiditis and inflammatory bowel diseases].
- Effects of epidermal growth factor on thyroglobulin and adenosine 3',5'-monophosphate production by cultured human thyrocytes.
- Thyrotropin modulates receptors for atrial natriuretic peptide on intact human Thyroid cells.
Schools
Univ Of Co Sch Of Med
Fitzsimons Army Med Center
Walter Reed Army Med Center
Procedures Preformed
- Continuous Glucose Monitoring
Conditions Treated
- Abnormal Thyroid
- Adrenal Insufficiency
- Adrenogenital Disorders
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Colorado Denver School of Medicine
Drug Facts
| NPI NUMBER | 1891701405 | |
| NPPES Provider LastName | AHMANN | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 972393011 | |
| NPPES Provider State | OR | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 2061.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 33.0 | |
| Percent Opioid Claims | 1.6 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891701405 |
| Last Name Of The Provider | AHMANN |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
Dr. Erica Zelfand, ND |
|
|
Dr. Fawn M. Wolf, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Farahnaz S. Joarder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda B. Lester, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James L. Neifing, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn G. Schuff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin S. Leblanc, MD
This Doctor is OpenDoctor Recommended.
|